Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response (Q33956478): Difference between revisions
Jump to navigation
Jump to search
Created claim: full work available at URL (P953): http://www.springerlink.com/index/pdf/10.1007/s11901-010-0047-1, Modify PubMed ID: 20676191 citation data from NCBI, Europe PMC and CrossRef |
Added reference to claim: full work available at URL (P953): http://www.springerlink.com/index/pdf/10.1007/s11901-010-0047-1, Modify PubMed ID: 20676191 citation data from NCBI, Europe PMC and CrossRef |
||||||||||||||
| Property / full work available at URL: http://www.springerlink.com/index/pdf/10.1007/s11901-010-0047-1 / reference | |||||||||||||||
stated in: Crossref DOI: 10.1007/S11901-010-0047-1 reference URL: https://api.crossref.org/works/10.1007/S11901-010-0047-1 retrieved: 14 June 2024
| |||||||||||||||
Latest revision as of 15:30, 14 June 2024
scientific article published on June 19, 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response |
scientific article published on June 19, 2010 |
Statements
1 reference
Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response (English)
1 reference
Sammy Saab
1 reference
Eric Chak
1 reference
19 June 2010
1 reference
1 reference
147-154
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference